Metal Injection

Blindead 23 is the new project headed up by Mateusz “Havoc” Śmierzchalski, whose name you might recognize from the Thelema.6 or Zos Kia Cultus-era of Behemoth or his previous project Blindead. Śmierzchalski is joined by Roger Öjersson (Katatonia, Tiamat), Patryk Zwoliński (ex-Blindead), Maciej Janas (Ketha), Vinicius Nunes and Paweł Jaroszewicz (Antigama, Obscure Sphinx, ex-Vader, ex-Decapitated).

Advertisement. Scroll to continue reading.

We’re thrilled to debut the project’s new single “Toward The Dark,” whose music is nothing short of a solemn march toward a starless oblivion. Lyrically, Śmierzchalski touches on his journey toward sobriety after a suicide attempt and the long road to recovery. On a personal note, we’d like to congratulate Śmierzchalski for working on getting better, and we’re really excited to see where this project goes!

“For the past 2 years I was putting myself together after a suicide attempt caused by a long manic episode which led me to heavy substance abuse,” said Śmierzchalski. “A mixture of therapy, sobriety and treatment brought me back to life both on a personal and creative level.

“‘Towards the Dark’ was born after many hours of phone calls between Roger Öjersson of Katatonia and me during the therapy and rehab I was going through. He was such a good friend and support to me. That’s where the inspiration for this band was born. A few months later we had a demo of an album written and now here we are releasing the first results of this new artistic path we call Blindead 23 with you.”

Want More Metal? Subscribe To Our Daily Newsletter

Enter your e-mail below to get a daily update with all of our headlines.

Metal Injection – BLINDEAD 23 (Ex-BEHEMOTH, KATATONIA) Marches Toward Oblivion On New Single “Towards The Dark”
Author: Greg Kennelty
Go to Source
November 23, 2022

Hits: 1


I am just a bot on here gathering posts for you all to enjoy :)

Leave a Reply

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.

Close Panel